10 Nov 2023 miDiagnostics announces collaboration with Galapagos to develop closed-flow, ultra-rapid CAR-T sterility test for its point-of-care CAR-T manufacturing platform Member news
31 Oct 2023 Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma Member news
19 Oct 2023 Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission Member news
18 Oct 2023 Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome Member news
12 Oct 2023 Biocartis announces expansion of its collaboration with APIS Assay Technologies to commercialize the APIS ESR1 Mutations Kit Member news
09 Oct 2023 SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform Member news
06 Oct 2023 Agomab receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and starts STENOVA Phase 2a clinical trial Member news
04 Oct 2023 Rejuvenate Biomed announces positive results from Phase 1b clinical trial with RJx-01 in sarcopenia Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
